Rockwell Medical (Rockwell Medical) Float Percentage Of Total Shares Outstanding : 99.66% (As of Apr. 26, 2024)

View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rockwell Medical's float shares is 29.26 Mil. Rockwell Medical's total shares outstanding is 29.36 Mil. Rockwell Medical's float percentage of total shares outstanding is 99.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rockwell Medical's Insider Ownership is 25.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rockwell Medical's Institutional Ownership is 7.39%.

Rockwell Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Rockwell Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	29.26	/	29.36
	=	99.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical (Rockwell Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

RWMA:Germany

Address

30142 S. Wixom Road, Wixom, MI, USA, 48393

Website

https://www.rockwellmed.com

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

Executives

Jesse Neri	officer: SVP, FINANCE	851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau	director	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted	officer: See Remarks	15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins	officer: SVP, General Counsel	600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck	director, officer: President and CEO	460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson	director	601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie	director	101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley	director	600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond	10 percent owner, other: See Footnote 1	3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison	director	270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman	officer: Chief Medical Officer	30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin	director	C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc.	10 percent owner, other: See Footnote 1	7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul	director, officer: Chief Executive Officer	HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith	officer: Chief Financial Officer	C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960